Literature DB >> 21347544

Molecular analysis of 51 unrelated pedigrees with late-onset multiple acyl-CoA dehydrogenation deficiency (MADD) in southern China confirmed the most common ETFDH mutation and high carrier frequency of c.250G>A.

Zhi-Qiang Wang1, Xue-Jiao Chen, Shen-Xing Murong, Ning Wang, Zhi-Ying Wu.   

Abstract

Multiple acyl-CoA dehydrogenation deficiency (MADD) is an autosomal recessive disease affecting amino acid, fatty acid, and choline metabolisms and is a common genetic defect responsible for lipid storage myopathy. Most forms of MADD are caused by a deficiency of electron transfer flavoprotein (ETF) or ETF dehydrogenase (ETFDH). However, its molecular feature has not been found uniformly in previous reports of Chinese patients. A large cohort of 56 late-onset MADD patients from 51 unrelated pedigrees in southern China was recruited to investigate a clear correlation between clinical phenotype and molecular genetic basis. All exons of ETFA, ETFB, and ETFDH, including the intron-exon boundaries, and 5' and 3' untranslated regions were directly sequenced. ETFDH deficiencies affected 94.1% (48/51) of the pedigrees. ETFDH-c.250G>A is the most common mutation, representing a high allelic frequency of 83.3% (80/96). Carrier frequency of c.250G>A is estimated to be 1.35% (7/520) in the normal population. A significant reduced expression of ETFDH was identified in the muscle of ETFDH-deficient patients. ETFDH deficiency is a major cause of riboflavin-responsive MADD in southern China, and c.250G>A is an important mutation that could be employed as a fast and reliable screening method.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21347544     DOI: 10.1007/s00109-011-0725-7

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  28 in total

1.  Mutation analysis of 218 Chinese patients with Wilson disease revealed no correlation between the canine copper toxicosis gene MURR1 and Wilson disease.

Authors:  Zhi-Ying Wu; Gui-Xian Zhao; Wan-Jin Chen; Ning Wang; Bo Wan; Min-Ting Lin; Shen-Xing Murong; Long Yu
Journal:  J Mol Med (Berl)       Date:  2006-01-28       Impact factor: 4.599

2.  Structure of electron transfer flavoprotein-ubiquinone oxidoreductase and electron transfer to the mitochondrial ubiquinone pool.

Authors:  Jian Zhang; Frank E Frerman; Jung-Ja P Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-18       Impact factor: 11.205

3.  High frequency of ETFDH c.250G>A mutation in Taiwanese patients with late-onset lipid storage myopathy.

Authors:  M-Y Lan; M-H Fu; Y-F Liu; C-C Huang; Y-Y Chang; J-S Liu; C-H Peng; S-S Chen
Journal:  Clin Genet       Date:  2010-12       Impact factor: 4.438

4.  Molecular cloning and expression of a cDNA encoding human electron transfer flavoprotein-ubiquinone oxidoreductase.

Authors:  S I Goodman; K M Axtell; L A Bindoff; S E Beard; R E Gill; F E Frerman
Journal:  Eur J Biochem       Date:  1994-01-15

5.  Molecular cloning and nucleotide sequence of cDNAs encoding the alpha-subunit of human electron transfer flavoprotein.

Authors:  G Finocchiaro; M Ito; Y Ikeda; K Tanaka
Journal:  J Biol Chem       Date:  1988-10-25       Impact factor: 5.157

6.  Novel mutations in ETFDH gene in Chinese patients with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.

Authors:  Lap-Kay Law; Nelson L S Tang; Joannie Hui; Simon L M Fung; Jos Ruiter; Ronald J A Wanders; Tai-Fai Fok; Christopher W K Lam
Journal:  Clin Chim Acta       Date:  2009-03-03       Impact factor: 3.786

7.  Riboflavin-responsive lipid-storage myopathy caused by ETFDH gene mutations.

Authors:  Bing Wen; Tingjun Dai; Wei Li; Yuying Zhao; Shuping Liu; Chunhua Zhang; Honghao Li; Jinling Wu; Danian Li; Chuanzhu Yan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-09-15       Impact factor: 10.154

8.  ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency.

Authors:  Rikke K J Olsen; Simon E Olpin; Brage S Andresen; Zofia H Miedzybrodzka; Morteza Pourfarzam; Begoña Merinero; Frank E Frerman; Michael W Beresford; John C S Dean; Nanna Cornelius; Oluf Andersen; Anders Oldfors; Elisabeth Holme; Niels Gregersen; Douglass M Turnbull; Andrew A M Morris
Journal:  Brain       Date:  2007-06-20       Impact factor: 13.501

9.  cDNA cloning and mitochondrial import of the beta-subunit of the human electron-transfer flavoprotein.

Authors:  G Finocchiaro; I Colombo; B Garavaglia; C Gellera; G Valdameri; N Garbuglio; S Didonato
Journal:  Eur J Biochem       Date:  1993-05-01

10.  Riboflavin therapy. Biochemical heterogeneity in two adult lipid storage myopathies.

Authors:  L Vergani; M Barile; C Angelini; A B Burlina; L Nijtmans; M P Freda; C Brizio; E Zerbetto; F Dabbeni-Sala
Journal:  Brain       Date:  1999-12       Impact factor: 13.501

View more
  28 in total

1.  Therapeutic advances in the management of Pompe disease and other metabolic myopathies.

Authors:  Corrado Angelini; Anna Chiara Nascimbeni; Claudio Semplicini
Journal:  Ther Adv Neurol Disord       Date:  2013-09       Impact factor: 6.570

2.  Multiple acyl-CoA dehydrogenation deficiency as decreased acyl-carnitine profile in serum.

Authors:  Bing Wen; Duoling Li; Wei Li; Yuying Zhao; Chuanzhu Yan
Journal:  Neurol Sci       Date:  2015-04-01       Impact factor: 3.307

3.  Clinical features and ETFDH mutation spectrum in a cohort of 90 Chinese patients with late-onset multiple acyl-CoA dehydrogenase deficiency.

Authors:  Jianying Xi; Bing Wen; Jie Lin; Wenhua Zhu; Sushan Luo; Chongbo Zhao; Duoling Li; Pengfei Lin; Jiahong Lu; Chuanzhu Yan
Journal:  J Inherit Metab Dis       Date:  2013-12-20       Impact factor: 4.982

4.  Spectrum analysis of common inherited metabolic diseases in Chinese patients screened and diagnosed by tandem mass spectrometry.

Authors:  Lianshu Han; Feng Han; Jun Ye; Wenjuan Qiu; Huiwen Zhang; Xiaolan Gao; Yu Wang; Wenjun Ji; Xuefan Gu
Journal:  J Clin Lab Anal       Date:  2014-05-05       Impact factor: 2.352

Review 5.  Riboflavin-responsive multiple Acyl-CoA dehydrogenation deficiency in 13 cases, and a literature review in mainland Chinese patients.

Authors:  Min Zhu; Xuan Zhu; Xueliang Qi; Ding Weijiang; Yajing Yu; Hui Wan; Daojun Hong
Journal:  J Hum Genet       Date:  2014-02-13       Impact factor: 3.172

6.  Fatty Acid oxidation disorders in a chinese population in taiwan.

Authors:  Yin-Hsiu Chien; Ni-Chung Lee; Mei-Chyn Chao; Li-Chu Chen; Li-Hsin Chen; Chun-Ching Chien; Hui-Chen Ho; Jeng-Hung Suen; Wuh-Liang Hwu
Journal:  JIMD Rep       Date:  2013-05-23

7.  Multiple Acyl-CoA Dehydrogenation Deficiency (Glutaric Aciduria Type II) with a Novel Mutation of Electron Transfer Flavoprotein-Dehydrogenase in a Cat.

Authors:  Shoichi Wakitani; Shidow Torisu; Taiki Yoshino; Kazuhisa Hattanda; Osamu Yamato; Ryuji Tasaki; Haruo Fujita; Koichiro Nishino
Journal:  JIMD Rep       Date:  2013-10-20

8.  Significant clinical heterogeneity with similar ETFDH genotype in three Chinese patients with late-onset multiple acyl-CoA dehydrogenase deficiency.

Authors:  Hong-Xia Fu; Xin-Yi Liu; Zhi-Qiang Wang; Ming Jin; Dan-Ni Wang; Jun-Jie He; Min-Ting Lin; Ning Wang
Journal:  Neurol Sci       Date:  2016-03-21       Impact factor: 3.307

9.  Characterization of ETFDH and PHGDH Mutations in a Patient with Mild Glutaric Aciduria Type II and Serine Deficiency.

Authors:  Amanat Ali; Nahid Al Dhahouri; Fatmah Saeed Ali Almesmari; Waseem Mahmoud Fathalla; Fatma Al Jasmi
Journal:  Genes (Basel)       Date:  2021-05-08       Impact factor: 4.096

10.  The story of equine atypical myopathy: a review from the beginning to a possible end.

Authors:  Dominique-Marie Votion
Journal:  ISRN Vet Sci       Date:  2012-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.